All Stories

  1. Electrochemical and Optical Detection of MicroRNAs as Biomarkers for Cancer Diagnosis
  2. 2, 4-dihydroxy-3, 4-methylenedioxychalcone activate mitochondrial apoptosis of Ehrlich ascites carcinoma cells
  3. Interactions of Vascular Endothelial Growth Factor and p53 with miR-195 in Thyroid Carcinoma: Possible Therapeutic Targets in Aggressive Thyroid Cancers
  4. Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma
  5. Pea lectin inhibits cell growth by inducing apoptosis in SW480 and SW48 cell lines
  6. Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma
  7. A peculiar case of Campylobacter jejuni attenuated aspartate chemosensory mutant, able to cause pathology and inflammation in avian and murine model animals
  8. Role of miR-193a in Cancer: Complexity and Factors Control the Pattern of its Expression
  9. Protein interactions of FAM134B with EB1 and APC/beta-catenin in vitro in colon carcinoma
  10. Optimizing treatment for children and adolescents with papillary thyroid carcinoma in post-Chernobyl exposed region: The roles of lymph node dissections in the central and lateral neck compartments
  11. GAEC1 mutations and copy number aberration is associated with biological aggressiveness of colorectal cancer
  12. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer
  13. RETREG1 (FAM134B ): A new player in human diseases: 15 years after the discovery in cancer
  14. miR-205 targets angiogenesis and EMT concurrently in anaplastic thyroid carcinoma
  15. Clinical and biological significance of miR-193a-3p targeted KRAS in colorectal cancer pathogenesis
  16. An amplification-free electrochemical detection of exosomal miRNA-21 in serum samples
  17. A PCR-free electrochemical method for messenger RNA detection in cancer tissue samples
  18. Surface Markers for the Identification of Cancer Stem Cells
  19. Cellular expression, in-vitro and in-vivo confirmation of GAEC1 oncogenic properties in colon cancer
  20. The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma
  21. MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signaling
  22. MicroRNA-186-5p overexpression modulates colon cancer growth by repressing the expression of the FAM134B tumour inhibitor
  23. Review of sequencing platforms and their applications in phaeochromocytoma and paragangliomas
  24. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma
  25. Quantification of gene-specific DNA methylation in oesophageal cancer via electrochemistry
  26. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer
  27. MicroRNA 183 family profiles in pheochromocytomas are related to clinical parameters and SDHB expression
  28. Optical biosensing strategies for DNA methylation analysis
  29. The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer
  30. Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours
  31. Genetic alterations in Krebs cycle and its impact on cancer pathogenesis
  32. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions
  33. Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer
  34. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy
  35. An electrochemical method for sensitive and rapid detection of FAM134B protein in colon cancer samples
  36. Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells
  37. Electrochemical Detection of FAM134B Mutations in Oesophageal Cancer Based on DNA-Gold Affinity Interactions
  38. Silent genetic alterations identified by targeted next-generation sequencing in pheochromocytoma/paraganglioma: A clinicopathological correlations
  39. Lipomatous tumours in adrenal gland: WHO updates and clinical implications
  40. Novel FAM134B mutations and their clinicopathological significance in colorectal cancer
  41. Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE2
  42. Quantum dot-based sensitive detection of disease specific exosome in serum
  43. Detection of regional DNA methylation using DNA-graphene affinity interactions
  44. Biennial versus annual treatment for schistosomiasis and its impact on liver morbidity
  45. Colorimetric and electrochemical quantification of global DNA methylation using a methyl cytosine-specific antibody
  46. Diagnosing schistosomiasis-induced liver morbidity: implications for global control
  47. Gold-loaded nanoporous iron oxide nanocubes: a novel dispersible capture agent for tumor-associated autoantibody analysis in serum
  48. Gold-loaded nanoporous superparamagnetic nanocubes for catalytic signal amplification in detecting miRNA
  49. Overexpression of microRNA-1288 in oesophageal squamous cell carcinoma
  50. Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma
  51. Expression pattern of miR-451 and its target MIF ( macrophage migration inhibitory factor ) in colorectal cancer
  52. Integrating gross pathology into teaching of undergraduate medical science students using human cadavers
  53. Characteristics of young adults of Belarus with post-Chernobyl papillary thyroid carcinoma: a long-term follow-up of patients with early exposure to radiation at the 30th anniversary of the accident
  54. Identification of Novel FAM134B (JK1) Mutations in Oesophageal Squamous Cell Carcinoma
  55. The expression profiles of the galectin gene family in colorectal adenocarcinomas
  56. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review
  57. Regulation of tumorigenesis in oral epithelial cells by defined reprogramming factors Oct4 and Sox2
  58. Clear cell carcinoma, not otherwise specified/hyalinising clear cell carcinoma of the salivary gland: The current nomenclature, clinical/pathological characteristics and management
  59. Interleukin-17A Contributes to the Control of Streptococcus pyogenes Colonization and Inflammation of the Female Genital Tract
  60. Inhibition of BRAF kinase suppresses cellular proliferation, but not enough for complete growth arrest in BRAF V600E mutated papillary and undifferentiated thyroid carcinomas
  61. “Googling” for Cancer: An Infodemiological Assessment of Online Search Interests in Australia, Canada, New Zealand, the United Kingdom, and the United States
  62. Interactive role of miR-126 on VEGF-A and progression of papillary and undifferentiated thyroid carcinoma
  63. Stage dependent expression and tumor suppressive function ofFAM134B(JK1) in colon cancer
  64. Survival of a newborn from a pregnant woman with rabies infection
  65. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era
  66. Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells
  67. Trenbolone Improves Cardiometabolic Risk Factors and Myocardial Tolerance to Ischemia-Reperfusion in Male Rats With Testosterone-Deficient Metabolic Syndrome
  68. Obesity Is Associated With Low NAD+/SIRT Pathway Expression in Adipose Tissue of BMI-Discordant Monozygotic Twins
  69. Dermatofibrosarcoma Protuberans: The role of tissue expansion in reconstructive surgery of the scalp
  70. Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review
  71. Multiple proliferation-survival signalling pathways are simultaneously active in BRAF V600E mutated thyroid carcinomas
  72. Deregulation of miR-126 expression in colorectal cancer pathogenesis and its clinical significance
  73. MicroRNA-126 suppresses proliferation of undifferentiated (BRAFV600E and BRAFWT) thyroid carcinoma through targeting PIK3R2 gene and repressing PI3K-AKT proliferation-survival signalling pathway
  74. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells
  75. Histopathological evaluation of parotid gland neoplasms in Queensland, Australia
  76. Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure
  77. Cancer stem cells in oesophageal squamous cell carcinoma: Identification, prognostic and treatment perspectives
  78. Modulatory role of miR-205 in angiogenesis and progression of thyroid cancer
  79. Epidemiological characteristics of human rabies in Henan province in China from 2005 to 2013
  80. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment
  81. Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management
  82. Morphological and clinical presentation of papillary thyroid carcinoma in children and adolescents of Belarus: The influence of radiation exposure and the source of irradiation
  83. A Synthetic M Protein Peptide Synergizes with a CXC Chemokine Protease To Induce Vaccine-Mediated Protection against Virulent Streptococcal Pyoderma and Bacteremia
  84. Diffuse sclerosing variant of papillary thyroid carcinoma—an update of its clinicopathological features and molecular biology
  85. Cancer stem cell: Fundamental experimental pathological concepts and updates
  86. Improvements in body composition, cardiometabolic risk factors and insulin sensitivity with trenbolone in normogonadic rats
  87. Ap-Menth-1-ene-4,7-diol (EC-1) fromEucalyptus camaldulensisDhnh. Triggers Apoptosis and Cell Cycle Changes in Ehrlich Ascites Carcinoma Cells
  88. Association Between BRAF V600E Mutation and Recurrence of Papillary Thyroid Cancer
  89. A Versatile Orthotopic Nude Mouse Model for Study of Esophageal Squamous Cell Carcinoma
  90. Cellular and Molecular Biology of Esophageal Cancer
  91. Downregulation of microRNA-498 in colorectal cancers and its cellular effects
  92. Update on paragangliomas and pheochromocytomas
  93. Estrogen Receptor Alpha Gene Expression in Breast Cancer Tissues from the Iranian Population - a Pilot Study
  94. The chronic enteropathogenic disease schistosomiasis
  95. Role of microRNA-34 family in cancer with particular reference to cancer angiogenesis
  96. Standardised reporting protocol for endoscopic resection for Barrett oesophagus associated neoplasia: expert consensus recommendations
  97. The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
  98. Adrenal Oncocytic Phaeochromocytoma with Putative Adverse Histologic Features: a Unique Case Report and Review of the Literature
  99. Glycomic Characterization of Respiratory Tract Tissues of Ferrets
  100. JK1 (FAM134B) gene and colorectal cancer: A pilot study on the gene copy number alterations and correlations with clinicopathological parameters
  101. JK1 (FAM134B) represses cell migration in colon cancer: a functional study of a novel gene
  102. Clinical management of advanced schistosomiasis: a case of portal vein thrombosis-induced splenomegaly requiring surgery
  103. BRAF inhibitors: From the laboratory to clinical trials
  104. Expression profile of endothelin 1 and its receptor endothelin receptor A in papillary thyroid carcinoma and their correlations with clinicopathologic characteristics
  105. mTOR expression in colorectal adenoma—reply
  106. The expression profiles of the galectin gene family in primary and metastatic papillary thyroid carcinoma with particular emphasis on galectin-1 and galectin-3 expression
  107. BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects
  108. Rabies in Henan Province, China, 2010–2012
  109. A review of the profile of endothelin axis in cancer and its management
  110. miR-126 in human cancers: Clinical roles and current perspectives
  111. Infection and Cellular Defense Dynamics in a Novel 17 -Estradiol Murine Model of Chronic Human Group B Streptococcus Genital Tract Colonization Reveal a Role for Hemolysin in Persistence and Neutrophil Accumulation
  112. Bilharzia in the Philippines: past, present, and future
  113. Synchronous colorectal cancer: Clinical, pathological and molecular implications
  114. How peculiar: the case of a rare tumour
  115. B-Raf mutation: A key player in molecular biology of cancer
  116. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers
  117. Co-regulatory potential of vascular endothelial growth factor–A and vascular endothelial growth factor–C in thyroid carcinoma
  118. Regulation of microRNA-1288 in colorectal cancer: Altered expression and its clinicopathological significance
  119. Melaleuca alternifolia Concentrate Inhibits in Vitro Entry of Influenza Virus into Host Cells
  120. BMI-1 activation is crucial in hTERT-induced epithelial–mesenchymal transition of oral epithelial cells
  121. HIV epidemic in men who have sex with men in Philippines
  122. Association Between BRAF V600E Mutation and Mortality in Patients With Papillary Thyroid Cancer
  123. Gene amplified in oesophageal cancer 1 (GAEC1)amplification in colorectal cancers and its impact on patient's survival
  124. OncogeneGAEC1regulatesCAPN10expression which predicts survival in esophageal squamous cell carcinoma
  125. Synthesis of 8-Hydroxyquinoline Derivatives as Novel Antitumor Agents
  126. Metachronous carcinomas in colorectum and its clinicopathological significance
  127. Epithelial-mesenchymal transition and mesenchymal-epithelial transition are essential for the acquisition of stem cell properties in hTERT-immortalised oral epithelial cells
  128. Myeloma-Induced Alloreactive T Cells Arising in Myeloma-Infiltrated Bones Include Double-Positive CD8 + CD4 + T Cells: Evidence from Myeloma-Bearing Mouse Model
  129. Altered JS-2 expression in colorectal cancers and its clinical pathological relevance
  130. Carcinoma ex Pleomorphic Adenoma: A Comprehensive Review of Clinical, Pathological and Molecular Data
  131. Clinicopathological significance of synchronous carcinoma in colorectal cancer
  132. Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant
  133. Correlation of the expression of human kallikrein-related peptidases 4 and 7 with the prognosis in oral squamous cell carcinoma
  134. Quantitative analysis of the expression of TGF-alpha and EGFR in papillary thyroid carcinoma: clinicopathological relevance
  135. Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: Potential markers for aggressive phenotypes
  136. Signet-ring cell carcinoma of colorectum—current perspectives and molecular biology
  137. GAEC1 and colorectal cancer: a study of the relationships between a novel oncogene and clinicopathologic features
  138. Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
  139. Irinotecan and colorectal cancer: the role of p53, VEGF-C and α-B-crystallin expression
  140. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma
  141. Giant primary plantar melanoma
  142. Irinotecan therapy and molecular targets in colorectal cancer: A systemic review
  143. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma
  144. Lam AK-Y, Ong K, Jafari Giv M, Ho Y-H. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types. Pathology 2008; 40: 580–5.
  145. p16 expression in colorectal adenocarcinoma: marker of aggressiveness and morphological types
  146. The clinicopathological roles of alpha-B-crystallin and p53 expression in patients with head and neck squamous cell carcinoma
  147. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity
  148. Treatment Outcomes in Anaplastic Thyroid Carcinoma: Survival Improvement in Young Patients With Localized Disease Treated by Combination of Surgery and Radiotherapy
  149. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity
  150. hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features
  151. Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists
  152. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer
  153. Surgical pathology of patients living in Kiribati
  154. Altered E-Cadherin Expression and p120 Catenin Localization in Esophageal Squamous Cell Carcinoma
  155. Staging Systems for Papillary Thyroid Carcinoma
  156. Telomerase activity of basal cell carcinoma in patients living in North Queensland, Australia
  157. Identification of a novel tumor transforming gene GAEC1 at 7q22 which encodes a nuclear protein and is frequently amplified and overexpressed in esophageal squamous cell carcinoma
  158. Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre
  159. Staging Systems for Papillary Thyroid Carcinoma
  160. Restaging of Differentiated Thyroid Carcinoma by the Sixth Edition AJCC/UICC TNM Staging System: Stage Migration and Predictability
  161. Clinicopathological Roles of Alterations of Tumor Suppressor Gene p16 in Papillary Thyroid Carcinoma
  162. Prognostic Factors in Papillary and Follicular Thyroid Carcinoma: Their Implications for Cancer Staging
  163. Aberrant FHIT protein expression in classical Hodgkin’s lymphoma: a potential marker
  164. Colorectal Mucinous Adenocarcinoma: The Clinicopathologic Features and Significance of p16 and p53 Expression
  165. Classical and Follicular Variant of Papillary Thyroid Carcinoma: A Comparative Study on Clinicopathologic Features and Long-term Outcome
  166. Papillary Microcarcinoma: Is There Any Difference between Clinically Overt and Occult Tumors?
  167. Primary squamous cell carcinoma of the rectum in a patient on immunosuppressive therapy
  168. Diffuse Sclerosing Variant of Papillary Carcinoma of the Thyroid: A 35-Year Comparative Study at a Single Institution
  169. Clinical relevance of Fas expression in oesophageal squamous cell carcinoma
  170. Investigation of Fuel Modification to Reduce Crossover in Direct Methanol Fuel Cells
  171. Increased Expression of Vascular Endothelial Growth Factor C in Papillary Thyroid Carcinoma Correlates with Cervical Lymph Node Metastases
  172. Follicular Thyroid Carcinoma
  173. Teaching clinical pathology by flexible delivery in rural sites
  174. High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma
  175. Synchronous Bilateral Breast Cancer in an Elderly Man
  176. Papillary Carcinoma of Thyroid: A 30-yr Clinicopathological Review of the Histological Variants
  177. Resuscitating the teaching of anatomical pathology in undergraduate medical education: Web-based innovative clinicopathological cases
  178. Optimizing the Treatment of AMES High-risk Papillary Thyroid Carcinoma
  179. Recurrent Laryngeal Nerve Palsy in Well-differentiated Thyroid Carcinoma: Clinicopathologic Features and Outcome Study
  180. Observer Variation in the Diagnosis of Follicular Variant of Papillary Thyroid Carcinoma
  181. Osteoprotegerin and Osteopontin Are Expressed at High Concentrations Within Symptomatic Carotid Atherosclerosis
  182. Chromosomal aberrations in esophageal squamous cell carcinoma among chinese: gain of 12p predicts poor prognosis after surgery
  183. Surgical Treatment for Primary Hyperparathyroidism in Hong Kong
  184. The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by real-time PCR
  185. Letter to the Editors
  186. Image analysis system for assessment of immunohistochemically stained proliferative marker (MIB-1) in oesophageal squamous cell carcinoma
  187. Low prevalence of incidentally discovered and early-stage esophageal cancers in a 30-year autopsy study
  188. High prevalence of RET proto-oncogene activation (RET/PTC) in papillary thyroid carcinomas
  189. Bilateral Adrenalectomy for Corticotrophin-Independent Macronodular Adrenocortical Hyperplasia
  190. Clinicopathologic significance of bcl-2 expression in the surgical treatment of oral tongue carcinoma
  191. Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3
  192. Prognostic factors of clinically stage I and II oral tongue carcinoma?A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, martinez-gimeno score, and pathologic features
  193. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance
  194. Autopsy Findings in Diabetic Patients: A 27-Yr Clinicopathologic Study with Emphasis on Opportunistic Infections and Cancers
  195. Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital
  196. Neurothekeoma of the paranasal sinuses in a 3-year-old boy
  197. Cytokeratin expression profiles in thyroid carcinomas
  198. Solid-cystic papillary tumor of the pancreas in children
  199. Primary squamous cell carcinoma of the thyroid gland: an entity with aggressive clinical behaviour and distinctive cytokeratin expression profiles
  200. The Clinicopathologic Significance of p53 and p21 Expression in the Surgical Management of Lingual Squamous Cell Carcinoma
  201. The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas
  202. A critical examination of adrenal tuberculosis and a 28-year autopsy experience of active tuberculosis
  203. Telomerase activity in small cell esophageal carcinoma
  204. The clinicopathological significance of bcl-2 expression in the surgical treatment of laryngeal carcinoma
  205. Routine parathyroid autotransplantation during thyroidectomy
  206. Malignant Insulinoma with Hepatoid Differentiation: A Unique Case with Alpha-Fetoprotein Production
  207. Morphological Analysis of Adrenal Glands: A Prospective Analysis
  208. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator
  209. Prognostic significance of serum p53 protein and p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma
  210. Nasal T/NK cell lymphoma: Report of 3 cases involving the palate
  211. Microsatellite alterations in squamous cell carcinoma of the head and neck — clustering of loss of heterozygosity in a distinct subset
  212. A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma
  213. Establishment and Characterization of HKESC-1, a New Cancer Cell Line from Human Esophageal Squamous Cell Carcinoma
  214. Insular and Anaplastic Carcinoma of the Thyroid
  215. Molecular biology of esophageal squamous cell carcinoma
  216. Giant myelolipoma in a patient with thalassemia intermedia
  217. Pancreatic Solid-cystic-papillary Tumor: Clinicopathologic Features in Eight Patients from Hong Kong and Review of the Literature
  218. The clinicopathological significance of p21 and p53 expression in esophageal squamous cell carcinoma: an analysis of 153 patients
  219. Teratoma in the region of adrenal gland: A unique entity masquerading as lipomatous adrenal tumor
  220. TUBERCULOSIS AND LYMPHOMA OF THE ILEUM: UNUSUAL ASSOCIATION AND CHALLENGE TO DIAGNOSIS
  221. SPLENIC VASCULAR LESIONS: UNUSUAL FEATURES AND A REVIEW OF THE LITERATURE
  222. Malignant melanoma of the oesophagus: clinicopathological features, lack of p53 expression and steroid receptors and a review of the literature
  223. OMENTAL FIBROMATOSIS PRESENTING AS AN INCARCERATED INGUINAL HERNIA
  224. Surgical implications of underestimation of adrenal tumour size by computed tomography
  225. Clinicopathological analysis of elective neck dissection for N0 neck of early oral tongue carcinoma11This study was supported by a research grant from the University of Hong Kong, Grant no. 335/048/0081, 337/048/0014.
  226. Expression of p21/waf1 in oral squamous cell carcinomas—correlation with p53 and mdm2 and cellular proliferation index
  227. Postoperative hypocalcemia in patients who did or did not undergo parathyroid autotransplantation during thyroidectomy: A comparative study
  228. C-erbB-2 protein expression in oesophageal squamous epithelium from oesophageal squamous cell carcinomas, with special reference to histological grade of carcinoma and pre-invasive lesions
  229. Expression of P-glycoprotein, a multidrug-resistance gene product, is Induced by radiotherapy in patients with oral squamous cell carcinoma
  230. Role of p53 Tumor Suppressor Gene in Pancreatic Endocrine Tumors of Chinese Patients
  231. Ret oncogene activation in papillary thyroid carcinoma: Prevalence and implication on the histological parameters
  232. Desmoplastic variant of ameloblastoma in Chinese patients
  233. Surgical Strategy for Insulinomas in Multiple Endocrine Neoplasia Type I
  234. Clinicopathological Analysis of Local Spread of Carcinoma of the Tongue 11The study was supported by a research grant from the University of Hong Kong, grant number 337/048/0014 and 335/048/0081.
  235. The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma
  236. Glomerulonephritis Associated with Basaloid Squamous Cell Carcinoma of the Oesophagus: A Possible Unusual Paraneoplastic Syndrome
  237. Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to thep53 gene mutation
  238. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: Do histological assessment and p53 overexpression predict chemo-responsiveness?
  239. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese and its relationship with p53 gene mutation
  240. Prevalence and predictive value ofp53 mutation in patients with oesophageal squamous cell carcinomas: A prospective clinico-pathological study and survival analysis of 70 patients
  241. Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature
  242. Gastrointestinal autonomic nerve tumor of the esophagus: A clinicopathologic, immunohistochemical, ultrastructural study of a case and review of the literature
  243. Cancer of the larynx in Hong Kong: a clinico-pathological study
  244. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma
  245. Expression of p53 and its relationship with human papillomavirus in penile carcinomas
  246. Absence of Epstein–Barr virus in penile carcinoma. A study of 42 cases using in situ hybridization
  247. Clinico-pathological correlation of glucagon-positive pancreatic endocrine tumours: a presentation of five cases
  248. Peliosis of the spleen: possible association with chronic renal failure and erythropoietin therapy.
  249. Expression of p53 in oesophageal squamous cell carcinoma in Hong Kong Chinese
  250. Cytokeratin expression in non-neoplastic oesophageal epithelium and squamous cell carcinoma of the oesophagus
  251. Small Cell Carcinoma of the Esophagus
  252. Large fetal ovarian cyst: prenatal diagnosis and treatment
  253. Sudden death associated with cardiac inflammatory pseudotumour